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Acid-Base Disorders in ICU Patients
Metabolic acid-base disorders are comnom clinical problems in ICU patients. 
Arterial blood gas analysis and anion gap (AG) are important laboratory data in 
approaching acid-base interpretation. When measuring the AG, several factors 
such as albumin have influence on unmeasured anions and unmeasured cations. 
If a patient has hypoalbuminemia, the AG should be adjusted according to the 
albumin level. High AG metabolic acidoses including lactic acidosis, ketoacidosis, 
and ingestion of toxic alcohols are common in ICU patients. The treatment 
target of lactic acidosis and ketoacidosis is not the acidosis, but the underlying 
condition causing acidosis. Gastric acid loss, diuretics, volume depletion, renal 
compensation for respiratory acidosis, hypokalemia, and mineralocorticoid 
excess are common causes of metaboic alkalosis. In chloride responsive 
metaboic alkalosis, volume and potassium repletion are mandatory. 
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Introduction
Acid-base disorders may be the most common clinical 
problem in the ICU
1). This review describes metobolic 
acidosis with high anion gap (AG), which contains lactic 
acidosis, ketoacidosis, and toxic ingestion. The final 
section also describes metabolic alkalosis. 
Metablic Acidosis
Metablic acidosis is a clinical disturbance characterized by 
a low arterial pH, a reduced plasma HCO3¯ concen  tration, 
and compensatory hyperventilation. Severe metabolic 
acidosis represents detrimental clinical effects including 
hyperventilation, decreased cardiac contractility and cardiac 
output, cardiac arrhythmia, pulmomary edema with 
minimal volume overload, and depressed central nervous 
system (CNS) function.
Plasma HCO3¯ concentration should be assessed if a 
patient is suspicious for metabolic acidosis. A low plasma 
HCO3¯ concentration, however, is not diagnostic for 
metabolic acidosis, since it is also generated by renal 
compensation to chonic respiratory alkalosis. Measurement 
of the arterial pH can exclude chonic respiratory alkalosis. 
The next stage of approach for patients with a metabolic 
acisois is calculation of serum AG, which is an estimate of 
increased unmeasured anions (UA) that helps to identify the 
cause of metabolic acidosis. The AG is used to determine 
whether metabolic acidosis is a result of an accumulation 
of non-volatile acids or a net loss of bicarbonate. All ions 
participate in electrochemical balance, including Na
+, Cl¯, 
HCO3¯, unmeasured cations (UC) and UA. Thus,
AG = UA – UC = Na
+ – (Cl¯ + HCO3¯)
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The normal value of the AG was originally set at 12 ± 
4 mEq/L. With the adoption of newer automated systems 
that more accurately measure serum elecrolytes, the normal 
value of the AG is 7 ± 4 mEq/L
2). This is a source of error in 
the interpretation of the AG.
Another source of error in the interpretation of the 
AG is albumin. Since hypoalbuminemia is common in 
ICU patients, the influence of albumin on the AG should 
be considered in all ICU patients. One of the methods 
of adjusting the AG in hypoalbuminemic patients is the 
following equation. 
Adjusted AG = Observed AG + 2.5 × [normal albumin – 
measured albumin (g/dL)]
3) 
There are two types in metabolic acidosis, a high AG or 
a normal AG
4). High AG metabolic acidosis is caused by 
addition of fixed acid to the extracellular fluid. The usual 
causes of high AG metabolic acidosis are lactic acidosis, 
ketoacidosis, end-stage renal failure, and toxic ingestion, 
including methanol, propylene glycol, and salicylates. 
Normal AG metabolic acidosis is a result of loss of HCO3¯ 
from the extracellular space, which is counterbalanced by a 
gain of Cl¯. The common causes of a normal AG metabolic 
acidosis include diarrhea, early renal failure, infusion of large 
volume isotonic saline, renal tubular acidosis, acetazolamide, 
and fistulas between ureter and gestrointestinal (GI) tract. 
The evaluation of acid-base disorders usually relies on 
arterial blood gas analysis. However, arterial blood may 
not be an accurate reflection of the acid-base conditions in 
peripheral tissues, especially in hemodynamically unstable 
patients. Weil et al. reported that during cardiopulmonary 
resuscitation (CPR), the arterial blood has a normal pH, 
while the venous blood shows severe acidemia (pH = 
7.15) (Fig. 1)
5). Although these results are under extreme 
conditions, medical personal have to remember that the 
acid-base status of arterial blood may not be an accurate 
reflection of the acid-base conditions in peripheral tissues 
when performing CPR . 
Organic Acidosis
1. Lactic acidosis
Lactate is the end product of anaerobic glycolysis. The 
anaerobic metabolism of 1 mole of glucose generates 47 kcal 
and 2 moles of lactate. The calories are 7% of energy yield 
from complete oxidation of glucose (673 kcal). Oxidation 
of 2 moles of lactate generates 652 kcal
6). In critically ill 
patients, lactate generation could be used as a source of 
energy by the heart and CNS (Fig. 2). 
Common etiologies of lactic acidosis in ICU patients are 
circulatory shock, sepsis, seizures, hepatic insufficiency, 
acute asthma, and malignancy. Thiamine deficiency and 
a variety of drugs can produce lactic acidosis including 
nucleoside reverse transcriptase inhibitors, acetaminophen, 
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Fig. 1. The pH in Arterial and Venous Blood during Cardiopulmonary 
Resuscitation.
*Modified from the study of Weil MH et al. Ref. 5.
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epinephrine, metformin, propofol, linezolid, and nitro-
prusside
7). 
There are many suggestive clues in the history, physical 
examination, laboratory tests, and response to therapy for 
the diagnosis of lactic acidosis. AG has to be elevated in 
lactic acidosis, but there are numerous reports of cases with 
normal AG lactic acidosis. Thus, AG should not be used as a 
screening test for lactic acidosis. Blood lactate concentration 
can be measured and levels above 4–5 mEq/L is abnormal. 
In patients with sepsis, a blood lactate level above 4 mEq/L 
may have prognostic value. 
The primary goal of therapy in lactic acidosis is correction 
of the underlying metabolic abnormality. The principal fear 
of acidosis is that acidosis is a myocardial depressant. The 
role of HCO3¯ administration in lactic acidosis, however, 
has been a source of great controversy. HCO3¯ therapy has 
possible risks, including paradoxical intracellular acidosis 
due to CO2 generation, volume expansion, hypernatremia, 
and overshoot metabolic alkalosis
8). There are several 
alternatives to HCO3¯ therapy, such as Carbicarb (Na2CO3 
+ NaHCO3), THAM (Tris-hydroxymethyl aminome-
thane), and dichloroacetate. However, published clinical 
experience with these agents is limited. Therefore, HCO3¯ 
has limited roles in the management of lactic acidosis. In 
the setting of severe acidosis (pH < 7.1) where the patient is 
deteriorating rapidly, HCO3¯ infusion can be attempted by 
administrating one-half of the estimated HCO3¯ deficit. 
HCO3¯ deficit (mEq) = 0.6 × wt (kg) × (15 – measured 
HCO3¯)
15 mEq/L is the end point for the plasma HCO3¯ to avoid 
overshoot alkalosis. 
2. Ketoacidosis
In conditions of reduced nutrient intake, adipose tissue 
releases free fatty acids, which are converted in the liver 
into ketones, acetoacetate (AcAc) and β-hydroxybutyrate 
(β-OHB). Both diminished activity of insulin and enhanced 
secretion of glucagon contribute to these changes
9). Since 
oxidative metabolism of ketones generates 4 kcal/g, these 
ketones can be used as an energy source by the heart and 
CNS (Fig. 3). The normal concentration of ketones in the 
blood is less than 1 mg/dL, but blood ketone levels increase 
tenfold after 3 days of starvation. The concentration of 
AcAc and β-OHB in blood is determined by the following 
reaction: 
AcAc + NADH ↔ β-OHB + NAD
The balance of this reaction favors the right side. The 
β-OHB : AcAc ratio ranges from 3 : 1 in diabetic ketoacidosis 
(DKA), to 8 : 1 in alcoholic ketoacidosis (AKA). The 
nitroprusside reaction is a commonly used method for 
detecting AcAc and acetone in blood and urine. A detectable 
reaction requires a minimum AcAc concentration of 30 
mg/dL. Because this reaction does not detect the β-OHB, 
false negative results will be possible in spite of severe 
ketoacidosis
10).
DKA is combined with hyperglycemia, but it may 
be mildly elevated or even normal in about 20% of the 
cases. Patients with AKA tend to be chronically ill and 
several comorbid conditions may be evident; including 
hyponatremia, hypokalemia, hypophosphatemia, 
hypomagnesemia, hypoglycemia and mixed acid-base 
disorders. Initially, the increase in ketoacids produces 
an elevated AG. Fluid replacement therapy, however, 
promotes ketoacid excretion in the urine and increases Cl¯ 
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Fig. 3. Metabolism of Ketones. CNS, central nervous system.Electrolyte Blood Press 8:66-71, 2010 • doi: 10.5049/EBP.2010.8.2.66    69
Copyright © 2010 The Korean Society of Electrolyte Metabolism
reabsorption in renal tubules. This can result in low HCO3¯ 
concentrations despite resolving ketoacidosis. Therefore, 
monitoring the ∆AG : ∆HCO3¯ ratio as therapy can be 
more informative. 1.0 in this ratio means pure ketoacidosis. 
The ratio decreases toward 0 as the ketoacidosis is 
resolved and high AG metabolic acidosis is replaced by the 
hyperchloremic acidosis. Management of ketoacidosis is 
intravenous insulin in the case of DKA, infusion of glucose 
in the case of AKA, volume replacement, and electrolyte 
replacement. HCO3¯ therapy does not improve the outcome 
in ketoacidosis and is not recommended
10, 11). 
3. Toxic alcohols
1) Ethylene Glycol
Ethylene glycol is an alcohol solvent used in antifreeze. 
This is the leading cause of death from chemical agents in 
the United States. Ethylene glycol is absorbed from the GI 
tract and metabolized by alcohol dehydrogenase (AD) in 
the liver producing to glycolic acid. This produces high AG 
metabolic acidosis. Serum lactate levels are also elevated in 
ethylene glycol poisoning because the formation of glycolic 
acid involves the conversion of NAD to NADH and this 
promotes the conversion of pyruvate to lactate
12). The final 
metabolite of ethylene glycol is oxalic acid, which can react 
with calcium to form a calcium oxalate complex. Calcium 
oxalate crystals can damage the renal tubules and produce 
acute kidney injury. 
Clinical presentation of ethylene glycol intoxication is 
nausea, vomiting, and inebriation, which mimic ethanol 
intoxication followed by acidosis, pulmonary edema, and 
cardiopulmonary dysfunction. Oliguric renal failure can 
be developed 24 hours after ingestion. Laboratory findings 
show a high AG metabolic acidosis with elevated osmolar 
gap. Serum lactate levels can be elevated. Hypocalcemia and 
calcium oxalate crystals in urine are present
13). 
Therapy is started based on high clinical suspicion. 
Treatment involves inhibition of AD with fomepizole or 
ethanol, and hemodialysis if necessary
14). Adjunct therapy 
with thiamine and pyridoxine can divert glyoxylic acid to 
nontoxic metabolites.
2) Methanol
Methanol (wood alcohol) is a common ingredient of 
shellac, varnish, windshield washer fluid, and solid cooking 
fuel. Methanol is rapidly absorbed from the GI tract and 
is metabolized by AD in the liver to formic acid. Tissues 
particularly susceptible to methanol are retina, optic nerve, 
and basal ganglia
15). 
Early signs are signs of inebriation. Many toxic mani-
festations including visual symptoms (decreased/blurred 
vision, snowfield blindness, scintillations, photophobia, 
and total blindness), depressed consciousness, coma, and 
generalized seizures are delayed 6–24 hours after ingestion. 
Examination of the eye reveals poorly reactive/unresponsive 
pupils, reduced acuity, optic disc hyperemia, retinal edema, 
increased blind spot, papilledema, and late optic atrophy. 
Laboratory studies are similar with ethylene glycol 
intoxication. Pancreatic enzymes can be also elevated and 
elevated CPK from rhabdomyolysis has been reported. 
Treatment is the same as ethylene glycol intoxication. 
Visual impairment is an indication for dialysis. Adjunct 
therapy with thiamine and pyridoxine is not indicated
15).
3) Propylene Glycol 
Propylene glycol is used as a drug vehicle or diluents 
to enhance water solubility of many hydrophobic intra-
venous drugs including lorazepam, diazepam, esmolol, 
nitroglycerin, and phenytoin. About 45% of propylene 
glycol is excreted by the kidney and remainder 
metabolized by the liver. This alcohol is metabolized by 
AD to lac  taldehyde and methylglyoxal, then to lactate 
and pyruvate
16). ICU patients receiving high dose of 
these drugs for more than 2 days can produce lactic 
acidosis and acute kidney injury. 
Signs of toxicity are agitation, coma, seizures, tachycardia, 
hypotension, and hyperlactatemia. This condition should 
be suspected in a patient with unexplained hyperlactatemia 
who is receiving a continuous infusion of high dose of these 
drugs for greater than 48 hours. 
Treatment is discontinuation of suspected drugs and 70      YK Oh  • Acid-Base Disorders in ICU Patients
Copyright © 2010 The Korean Society of Electrolyte Metabolism
intermittent hemodialysis
16). 
Metabolic alkalosis
Metabolic alkalosis is characterized by increased HCO3¯ 
concentration in extracellular space with com  pensatory 
increase in arterial PCO2. Loss of gastric secretions, diu-
retics, volume depletion, hypokalemia, organic anions, 
and chronic CO2 retention are responsible for most 
cases of metabolic alkalosis in ICU patients. The clinical 
consequences of severe metabolic alkalosis are neurologic 
manifestations, hypoventilation, and decreased systemic 
oxygenation. 
Metabolic alkalosis is classified as chloride-responsive 
and chloride-resistant, according to the urinary Cl¯ 
concentration. Urine Cl¯ of chloride–responsive metabolic 
alkalosis is less than 15 mEq/L. Gastric acid loss, remote 
use of diuretics, volume depletion, and renal compensation 
for respiratory acidosis are common causes of this type of 
metabolic alkalosis. Chloride-resistant metabolic alkalosis 
is characterized by elevated urinary Cl¯ excretion (above 
25 mEq/L). Causes of this type of metabolic alkalosis are 
mineralocorticoid excess or potassium depletion
17). 
Most of the metabolic alkalosis seen in ICU patients are 
chloride responsive. Cl¯ replacement is important therapy 
for metabolic alkalosis. Volume of normal saline needed is 
calculated by estimating the Cl¯ deficit
17). 
Cl¯ deficit (mEq) = 0.2 × wt (kg) × (normal Cl¯ – actual 
Cl¯)
Volume of saline (L) = Cl¯ deficit/154
Since hypokalemia can promote metabolic alkalosis, 
correction of hypokalemia is important for correcting 
metabolic alkalosis. For patients who have severe metabolic 
alkalosis (pH > 7.55 with HCO3¯ > 40 mEq/L) and have 
failed correction of metabolic alkalosis by saline infusion or 
potassium replacement, dilute solution of HCl infusion is 
indicated. The amount of HCl is determined by estimating 
H
+ deficit.
H
+ deficit (mEq) = 0.5 × wt (kg) × (actual HCO3¯ –
desired HCO3¯)
The HCl solution for intravenous use is 0.1N HCl. It must 
be infused via central vein and the infusion rate should not 
exceed 0.2 mEq/kg/hr
18). To manage the chloride-resistant 
metabolic alkalosis caused by mineralocorticoid excess, 
5–10 mg/kg of acetazolamide can be used. Acetazolamide 
promotes potassium depletion and volume depletion
19). 
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